FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Unichem Pharmaceuticals Topiramate Tablets Recall

Topiramate Tablets, USP 50 mg, 500-count bottles, Rx Only, Manufactured by: Unichem Lab…

UNICHEM PHARMACEUTICALS USA INC · East Brunswick, NJ

Risk level
Class III
Reported by FDA
Dec 1, 2021
Recall ID
D-0255-2022
Check your lot numberHow we source this data

Summary

Unichem Pharmaceuticals recalled Topiramate Tablets starting Oct 25, 2021. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0255-2022 on Dec 1, 2021. Reason: Discoloration. Status: Terminated.

Why it was recalled

Discoloration

Product description

Topiramate Tablets, USP 50 mg, 500-count bottles, Rx Only, Manufactured by: Unichem Laboratories LTD, Ind. Area. Meerut Road, Ghaziabad -201 003, India. Manufactured for: Unichem Pharmaceuticals (USA), Inc., East Brunswick, NJ 06815, NDC 29300-116-05.

Lot numbers, UPCs & expiration codes

Lot #: ZTPM20044, Exp. Date 09/30/2022

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0255-2022
Classification
Class III
Status
Terminated
Recall initiated
Oct 25, 2021
FDA report date
Dec 1, 2021
Quantity
1284 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
UNICHEM PHARMACEUTICALS USA INC

Original FDA data

Every field from FDA enforcement report D-0255-2022, exactly as published.

Show all FDA fields
City
East Brunswick
State
NJ
Status
Terminated
Country
United States
Event ID
88891
Address
1 Tower Center Blvd Ste 2200
Code information
Lot #: ZTPM20044, Exp. Date 09/30/2022
Postal code
08816-1145
Report date
Dec 1, 2021
Product type
Drugs
Recall number
D-0255-2022
Classification
Class III
Recalling firm
UNICHEM PHARMACEUTICALS USA INC
Product quantity
1284 bottles
Termination date
Oct 12, 2022
Reason for recall
Discoloration
Voluntary / mandated
Voluntary: Firm initiated
Product description
Topiramate Tablets, USP 50 mg, 500-count bottles, Rx Only, Manufactured by: Unichem Laboratories LTD, Ind. Area. Meerut Road, Ghaziabad -201 003, India. Manufactured for: Unichem Pharmaceuticals (USA), Inc., East Brunswick, NJ 06815, NDC 29300-116-05.
Distribution pattern
Nationwide within the United States
Recall initiation date
Oct 25, 2021
Center classification date
Nov 19, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0255-2022, published Dec 1, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls